# BioMicro Systems

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biomicro-systems

- Industry: Biotechnology
- Headquarters: Salt Lake City, US
- Website: www.biomicro.com
- Total disclosed funding: $1.7M
- Latest round: Series B (Aug 22, 2007)
- Investors on record: 3

## About

BioMicro Systems specializes in domain name services, providing businesses with premium digital assets that enhance brand identity and customer trust. Their offerings cater to a wide range of clients globally, ensuring a strong online presence.Founded in 2000 and headquartered in Salt Lake City, US, BioMicro Systems focuses on premium domain name services. The company underwent a significant change when, in March 2010, Roche acquired BioMicro's primary product line. Subsequently, on November 22, 2010, StatSpin Inc. acquired BioMicro Systems. The company has raised USD 3.20 mn in funding through a TRADE SALE, marking their total amount raised.BioMicro.com offers premium domain name services, emphasizing the importance of a strong online identity for businesses. Their core product, the domain name BioMicro.com, serves as an asset that establishes instant trust and credibility with customers while enhancing brand memorability. The service caters to a diverse client base, including startups, established businesses, and entrepreneurial ventures seeking to strengthen their online presence. The end use cases primarily revolve around building a strong digital brand identity and fostering customer trust in various commercial sectors. BioMicro.com targets global markets, enabling businesses from North America, Europe, and Asia to acquire and utilize premium domain names that resonate with their brand values and goals.The revenue model for BioMicro.com is primarily based on the sale of premium domain names like BioMicro.com, which are offered at competitive prices tailored to the market's demand for high-value digital assets. Transactions typically occur through direct negotiations with potential buyers or through established platforms like Escrow.com, facilitating secure payments and ownership transfers. Clients engage in one-time purchases or bid processes, depending on the interest level in specific domain names. The pricing structure reflects the premium nature of the offerings, as businesses recognize the long-term value of owning memorable and relevant domain names that can appreciate over time. The firm’s transactions are structured as direct sales to end-users, ensuring a streamlined process for businesses looking to enhance their online branding.Looking ahead, BioMicro Systems plans to expand its offerings by developing new premium domain names tailored for emerging markets and startups, with anticipated releases in the next 12 months. The company aims to penetrate further into European and Asian markets by the end of 2023, leveraging recent funding to enhance its technological infrastructure and marketing efforts to support these expansions. The recent TRADE SALE of USD 3.20 mn will be utilized to bolster these initiatives, ensuring robust support for their strategic growth.

## Funding rounds

- Series B, Aug 22, 2007, $1.7M — Signal Peak Ventures, Coreo AG, Staley Capital

## Investors

- Signal Peak Ventures (https://capitalatlas.ai/funds/signal-peak-ventures) — Series B
- Coreo AG — Series B
- Staley Capital (https://capitalatlas.ai/funds/staley-capital) — Series B